Effect of Shatavaryadi Ghrita in Asrigdara (menorrhagia).

An Open Label Single Arm Clinical Study to Evaluate The Efficacy of Shatavaryadi Ghrita in Asrigdara w.s.r. Dysfunctional Uterine Bleeding - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/10/095814

Enrollment

Registered

2025-10-09

Start date

Unknown

Completion date

Unknown

Last updated

2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N939- Abnormal uterine and vaginal bleeding, unspecified Health Condition 2: R688- Other general symptoms and signs

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patient presenting with excessive, prolonged menstrual bleeding, intermenstrual bleeding for 2 months irrespective of parity married female complaint of menorhagia from 3 cycles or more than 3 cycle

Exclusion criteria

Exclusion criteria: unmarried below 18 and above 45 yrs of age on going research study recent abortion, anemia, tb, hypertension, dm, hypo or hyperthyroidism, cardiac disease, renal parynchymal disease, jaundice, benign or malignant growth, cervical errosion, cervical polyp, pid, pterovaginal prolapse, endometriosis, h/o IUD

Design outcomes

Primary

Measure	Time frame
Efficacy of Shatavaryadi Ghruta in asrugdara could me more as compared to any other drug.Timepoint: The effect can be seen in 4 to 8 weeks	—

Secondary

Measure	Time frame
ALONG WITH ASRIGDARA IMPROVEMENT OF OTHER YONIVYAPAD MAY IMPROVETimepoint: 3 MONTHS	—

Countries

India

Contacts

Public ContactDr Shivangi Yadav

Shri Babu Singh Jay Singh Ayurvedic Medical College and Hospital

ayurlord@gmail.com7652080752

Outcome results